🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 13471N201 (prev. 13471N102 )
- Market Cap
- Micro Cap
- ADR Ratio
- 1:2
- Previous Symbol
- CANFY (changed 11/19/2013)
Business: Can-Fite Biopharma Ltd is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases.
Notes: May 1, 2019 -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, announced today that the Company will change the ratio of its American Depositary Shares (ADSs) to ordinary shares from one (1) ADS representing two (2) ordinary shares to a new ratio of one (1) ADS representing thirty (30) ordinary shares. The ratio change will be effective on May 10, 2019.
Company Contact
- CEO
- James S. Corl
- CFO
- Arjun Mahalingam
- Investor Relations
- 800-716-4880 · info@canfite.co.il